−0.150SEK
−23.94 MSEK
40.61 M
About CHOSA ONCOLOGY AB
Sector
CEO
Peter Buhl Jensen
Website
Headquarters
Lund
FIGI
BBG00BZY1803
Chosa Oncology AB operates as a biotechnology company, which focuses on developing drugs related to cancer treatment. Its products include iCIP, LiPlaCis and DRP. The company was founded in 2023 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CHOSA is 0.998 SEK — it has decreased by 0.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange CHOSA ONCOLOGY AB stocks are traded under the ticker CHOSA.
CHOSA stock is 7.53% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is CHOSA ONCOLOGY AB there?
Yes, you can track CHOSA ONCOLOGY AB financials in yearly and quarterly reports right on TradingView.
CHOSA stock has risen by 15.78% compared to the previous week, the month change is a 10.89% rise, over the last year CHOSA ONCOLOGY AB has showed a 23.82% decrease.
CHOSA net income for the last quarter is −2.82 M SEK, while the quarter before that showed −1.15 M SEK of net income which accounts for −145.09% change. Track more CHOSA ONCOLOGY AB financial stats to get the full picture.
Today CHOSA ONCOLOGY AB has the market capitalization of 64.74 M, it has decreased by 4.27% over the last week.
No, CHOSA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHOSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHOSA ONCOLOGY AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHOSA ONCOLOGY AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHOSA ONCOLOGY AB stock shows the strong buy signal. See more of CHOSA ONCOLOGY AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.